April 2010

Recent developments in the field of active cancer immunotherapy foreshadow that the "next big thing" in cancer drugs may be on the way.

In this Scrip 100 article, author Malini Guha discusses the current state of cancer immunotherapy research, the controversial history of the field, and the great hope of this game-changing approach to cancer treatment, prevention, and control.

Presented in clear, easy-to-understand language, the article features extensive commentary and insight from Cancer Research Institute Scientific Advisory Council Director Dr. Lloyd J. Old, and references a number of CRI-funded laboratory and clinical studies that are shaping the future of cancer treatment.

Please make a gift today to support the Cancer Research Institute. With your help, we can continue to fund the clinical trials and laboratory research needed to advance new, life-saving cancer therapies.

Stay Informed
Subscribe to our free e-newsletter, Cancer ImmuNews, to receive updates on the latest research breakthroughs from the Cancer Research Institute.